PLG and angioedema: In the context of ACEi/ARB-induced angioedema, a plausible hypothesis is that decreased plasma plasminogen levels lead to naturally lower bradykinin levels, in which case this variant may be protective against bradykinin accumulation during treatment with ACEi/ARB.